Kuebler JP - Search Results

1

Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.

Kuebler JP, Benedetti J, Schuller DE, Ensley J, Grunberg SM, Muirhead MJ, Richert-Boe KE, Marshall ME. Kuebler JP, et al. Invest New Drugs. 1994;12(4):341-4. doi: 10.1007/BF00873052. Invest New Drugs. 1994. PMID: 7775138 Clinical Trial.

2

Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

Kuebler JP, Metch B, Schuller DE, Keppen M, Hynes HE. Kuebler JP, et al. Invest New Drugs. 1991 Nov;9(4):373-4. doi: 10.1007/BF00183585. Invest New Drugs. 1991. PMID: 1725172 Clinical Trial. No abstract available.

3

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: kuebler jp. Invest New Drugs. 2001;19(4):311-5. doi: 10.1023/a:1010657609609. Invest New Drugs. 2001. PMID: 11561690 Clinical Trial.

4

Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.

Samlowski WE, Moon J, Kuebler JP, Nichols CR, Gandara DR, Ozer H, Williamson SK, Atkins JN, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: kuebler jp. Cancer Invest. 2007 Apr-May;25(3):182-8. doi: 10.1080/07357900701209061. Cancer Invest. 2007. PMID: 17530488 Clinical Trial.

5

Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.

Ramaswamy B, Mrozek E, Kuebler JP, Bekaii-Saab T, Kraut EH. Ramaswamy B, et al. Among authors: kuebler jp. Invest New Drugs. 2011 Apr;29(2):347-51. doi: 10.1007/s10637-009-9338-1. Epub 2009 Oct 21. Invest New Drugs. 2011. PMID: 19844661 Free PMC article. Clinical Trial.

6

Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.

Kuebler JP, King GW, Triozzi P, Moore T, Kraut EH. Kuebler JP, et al. Invest New Drugs. 2001;19(4):327-8. doi: 10.1023/a:1010622129173. Invest New Drugs. 2001. PMID: 11561693 Clinical Trial. No abstract available.

7

A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339).

Macdonald JS, Jacobson JL, Ketchel SJ, Weiss G, Taylor S, Mills G, Kuebler JP, Rivkin S, Conrad M. Macdonald JS, et al. Among authors: kuebler jp. Invest New Drugs. 2000 May;18(2):199-202. doi: 10.1023/a:1006390216220. Invest New Drugs. 2000. PMID: 10857998 Clinical Trial.

8

A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study.

Whitehead RP, Fleming TR, Macdonald JS, Ahmann FR, Garewal HS, Kuebler JP. Whitehead RP, et al. Among authors: kuebler jp. Invest New Drugs. 1991 Nov;9(4):345-7. doi: 10.1007/BF00183578. Invest New Drugs. 1991. PMID: 1804811 Clinical Trial.

9

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study.

Kuebler JP, Goodman PJ, Brown TD, Crawford ED, Reitz CL, Knight WA 3rd, Kish JA. Kuebler JP, et al. Invest New Drugs. 1990 Aug;8(3):307-9. doi: 10.1007/BF00171843. Invest New Drugs. 1990. PMID: 2125585 Clinical Trial. No abstract available.

10

A phase II study of 9-aminocamptothecin in patients with refractory breast cancer.

Kraut EH, Balcerzak SP, Young D, O'Rourke MA, Petrus JJ, Kuebler JP, Mayernik DG. Kraut EH, et al. Among authors: kuebler jp. Cancer Invest. 2000;18(1):28-31. doi: 10.3109/07357900009023059. Cancer Invest. 2000. PMID: 10701364 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters